No other drug delivery technology performs on the level of RoverMed’s Crystalline Ultra-Small Particle (CUSP) technology. We deliver:
Different kinds of DNA and RNA for cancer therapies, gene therapies, gene-editing, RNAi, immuno-oncology, vaccines, etc. There is virtually no disease that can’t be treated with DNA or RNA therapies if the therapies can be delivered and the target is known.
Proteins, Peptides, Carbohydrates, and Antibodies can be readily employed to target different diseases – a significant competitive delivery advantage as well as attraction for new partners.
Intravenous, Subcutaneous, Topical or Device – enhances drug efficacy and patient convenience.
Uniquely provides intact delivery of nucleic acid drug cargos to challenging disease sites using a versatile, precision ligand-targeted platform.
A powerful combination of a partner’s drug with our targeted delivery system will enable therapeutic success for the next generation of drugs for unmet patient needs!